Sanjay Subramanian - Mar 21, 2022 Form 3 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
SVP, CFO
Signature
/s/ Sanjay Subramanian
Stock symbol
INZY
Transactions as of
Mar 21, 2022
Transactions value $
$0
Form type
3
Date filed
3/22/2022, 04:08 PM
Previous filing
Jan 5, 2022
Next filing
Apr 20, 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit Index: 24.1 Power of Attorney